Citation:Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, et al 2012

From Cancer Guidelines Wiki

Citation


Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, et al. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology 2012 Oct;143(4):917-26.e1 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22796132.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Cancer Prevention Network, Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, et al 2012Are there any treatments that prevent progression of BO to cancer?Professor David Watson MBBS, MD, FRACScompleted
Cancer Prevention Network, Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, et al 2012 2What is the appropriate management of low grade dysplasia in patients with BO?Dr Andrew Taylor MBBS MD FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Are there any treatments that prevent progression of BO to cancer?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there any treatments that prevent progression of BO to cancer?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the appropriate management of low grade dysplasia in patients with BO?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the appropriate management of low grade dysplasia in patients with BO?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Are there any treatments that prevent progression of BO to cancer?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Falk_GW,_Buttar_NS,_Foster_NR,_Ziegler_KL,_Demars_CJ,_Romero_Y,_et_al_2012&oldid=95013"